Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...
The FDA ap­proved Eli Lil­ly’s Omvoh in Crohn’s dis­ease, the com­pa­ny an­nounced Wednes­day, hand­ing the drug its sec­ond in­di­ca­tion af­ter giv­ing it a green light … ...
ABILENE, Texas (KTAB/KRBC) – After being under construction in 2024, the fast-food restaurant Braum’s opened its first of three new locations in Abilene. The first store is located at 1327 ...
Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...
ABILENE, Texas (KTAB/KRBC) – The Abilene Police Department is mourning the loss of a school resource officer. Officer Daniel Henning, who was serving as the School Resource Officer at Craig ...
Copyright 2025 The Associated Press. All Rights Reserved. Texas Tech forward Darrion Williams (5) chats with Kansas State head coach Jerome Tang as he waits to go ...
Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Eli Lilly shares could remain under the microscope on Wednesday after falling sharply ...
Bill Belichick has just fired a playoff warning shot in the direction of Patrick Mahomes and the Kansas City Chiefs. But in a nice way. The iconic Belichick - well-known for his gruffness - is in ...
What will Eli Lilly do with all its cash from Mounjaro and Zepbound? What does CEO Dave Ricks think it would take for the company to reach a $1 trillion market capitalization? And how does Ricks ...
Eli Lilly (NYSE: LLY) saw its stock decline sharply by 6.5% on January 14, following the release of its fourth-quarter 2024 revenue guidance, which fell short of Wall Street expectations. The ...
Lilly plans to share its full Q4 2024 results on 6 February 2025. Credit: JHVEPhoto via Getty Images. Eli Lilly has announced a $400m reduction in its 2024 revenue forecast, marking a 3% shortfall ...